Delivery Order SPE2DB20D3103-SPE2DB25FP5T5
- Not listed
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,956,698 units of Rifampin 300 mg capsules. The contract, valued at $1,203.66, has an ultimate completion date of March 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $18,609.46 and an ultimate completion date of August 29, 2024. It is a firm-fixed-price contract, with no set-aside designation....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rifampin 300 mg capsules, a critical medication, to support military healthcare programs globally. The delivery order, valued at $1,802.06, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 capsules of 300 mg Rifampin, an antibiotic medication, with a ceiling value of $10,237.44. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
- The Defense Logistics Agency awarded a $2,494.04 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562178123 RIFAMPIN 300 MG CAPSULE 60S. The prime contractor will deliver the rifampin capsules to a location in Conshohocken, Pennsylvania by September 15, 2023 to fulfill requirements under an indefinite-delivery/indefinite-quantity contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will utilize...
- The Defense Logistics Agency Troop Support Medical awarded a $115,810 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 300mg rifampin capsules. Under this contract, Amerisourcebergen will deliver 100 count bottles of the antibiotic medication to a location in Conshohocken, Pennsylvania by July 18, 2023 to support DLA Troop Support Medical programs. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,243,500 units of Rifampin 300 mg capsules. The award has a ceiling value of $61,426.00 and a period of performance through July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
- The Defense Logistics Agency awarded a delivery order valued at approximately $580 to Amerisourcebergen Drug Corporation for 4561431483 RIFAMPIN 300 MG CAPSULE 60S. The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of rifampin capsules to a facility in Conshohocken, Pennsylvania. Performance is required from July 7 through July 10, 2023. The firm fixed price order was awarded without any set aside designations to the...
- This is a $5,131.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The contract has a performance period extending through July 7, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $27,852.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5T5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis and other mycobacterial infections, making this pharmaceutical procurement essential for military healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp demonstrates significant capacity to fulfill DLA's medical procurement requirements across multiple therapeutic domains and geographic locations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/18/25 |